Nita A. Limdi PharmD, PhD, MSPH, FAHA

Nita A. Limdi, Pharm.D., Ph.D., a professor in the Department of Neurology in the University of Alabama at Birmingham School of Medicine, has been awarded a Midcareer Investigator Award in patient-oriented research by the National Institutes of Health. The purpose of these awards, known as K24 grants, is to provide protected time to devote to patient-oriented research and to act as research mentors for clinical residents, clinical fellows and/or junior clinical faculty.

Limdi, the interim director of the UAB Hugh Kaul Personalized Medicine Institute, is engaged in antithrombotic therapy pharmacogenomics research. Antithrombotic — or anticlotting — drugs commonly known as blood thinners, are widely used but can be challenging to prescribe. Limdi’s research focus is to understand the clinical, environmental and genetic factors that influence variability in antithrombotic response and to use this information to personalize antithrombotic treatment.